NEW YORK, Nov. 7, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of InfuSystems Holdings, Inc. ("InfuSystems" or the "Company") (NYSE: INFU) (ISIN: US45685k1025). Investors are advised to contact Robert S. Willoughby at firstname.lastname@example.org or 888-476-6529, ext. 9980.
The investigation concerns whether InfuSystems and certain of its officers and/or directors have violated the federal securities laws.
On November 7, 2016, InfuSystems announced that "the Company's audited financial statements for the fiscal year ended December 31, 2015, and the Company's unaudited financial statements for each of the fiscal quarters ended March 31, 2015 through June 30, 2016 should no longer be relied upon," citing "an error related to an overstatement of estimated accounts receivable collections which in turn overstated revenues and pre-tax income by a corresponding amount." InfuSystems disclosed that the Company's "Audit Committee believes that material adjustments to the Financial Statements are required and that the Company will need to restate the Financial Statements."
On this news, InfuSystem's share price fell $1.00, or 38.46%, to close at $1.60 on November 7, 2016.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
Robert S. Willoughby
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-infusystems-holdings-inc--infu-300358722.html
SOURCE Pomerantz LLP